NCT00272831: The Use of Cilostazol in Patients With Diabetic Nephropathy |
|
|
| Completed | 4 | 62 | RoW | Cilostazol, Pletaal, Placebo | Chinese University of Hong Kong | Diabetes Mellitus, Type 2, Diabetes Complications | 12/07 | 12/07 | | |
NCT00823849: Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker |
|
|
| Completed | 4 | 200 | RoW | Cilostazol, pletaal, Probucol, Changtai, Cilostazol+Probucol, Pletaal and Changtai, Control Group, Routine treatment | Otsuka Beijing Research Institute | Type 2 Diabetes Mellitus, Arteriosclerosis Obliterans | 08/09 | 03/10 | | |
ASCEND, NCT01076478: Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines |
|
|
| Completed | 4 | 47 | RoW | Cilostazol, Cilostazol, Pletaal, Pletal | Otsuka Pharmaceutical, Inc., Philippines | Polyneuropathy | | 11/09 | | |
